Literature DB >> 27375864

Crystal structure of a bioactive sesquiterpene isolated from Artemisia reticulata.

A K Bauri1, Sabine Foro2, Nhu Quynh Nguyen Do3.   

Abstract

The title compound, C15H24O2 {systematic name: 1-[6-hy-droxy-7-(propan-2-yl)-4-methyl-idene-2,3,3a,4,5,6,7,7a-octa-hydro-1H-inden-1-yl]ethanone} was iso-la-ted from A. reticulata by column chromatography over silica gel by gradient solvent elution. The mol-ecule comprises a bi-cyclo-[4.3.0]nonane ring bearing acet-oxy, hy-droxy and isopropyl substituents, and an exocyclic double bond on the cyclo-hexane ring. In the bicyclic skeleton, the cyclo-hexane ring adopts a chair conformation ring and the cyclo-pentane ring is in an envelope conformation. In the crystal, mol-ecules are linked by O-H⋯O hydrogen bonds, forming chains along [010]. These chains are cross-linked by C-H⋯O hydrogen bonds.

Entities:  

Keywords:  Artemisia reticulata; anti­proliferative property; crystal structure; isolation; sesquiterpene

Year:  2016        PMID: 27375864      PMCID: PMC4910329          DOI: 10.1107/S2056989016003236

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The title compound is a natural product, which has been isolated from the Indian herb A. reticulata by column chroma­tography over silica gel. A. reticulata (family: Asteraceae) is a traditional herb which has many applications in folklore medicine for conventional therapy against several diseases such as malaria (Klayman et al., 1984 ▸; Malagon et al., 1997 ▸; Newton & White, 1999 ▸), cancer (Efferth et al., 2001 ▸; Lai et al., 1995 ▸), cardiovascular (Guantai et al., 1999 ▸), vasodilatory (Walker, 1996 ▸), hepatitis (Aniya et al., 2000 ▸) and diabetes (Iriadam et al., 2006 ▸). It is found as a constituent in many ayurvedic or herbal drug preparations such as forkolin and Afsanteen in Indian traditional medicinal systems (Nadkarni, 1954 ▸; Satyavati et al., 1987 ▸; Subramoniam et al., 1996 ▸; Drury, 1978 ▸). The Artemisia species are a rich source of bioactive sesquiterpenenoids (Klayman et al., 1984 ▸) such as artemisinin, artemisin etc. Artimisinin and artemisin are secondary metabolites isolated from herbs of the species A. annua (Klayman, 1985 ▸) belonging to the sesquiterpene class. The title mol­ecule possesses anti­plasmodial activity and it is now under clinical trial for the treatment of malaria. Our group are currently searching for artemisin, artemisinin or their analogues from other varieties of Artemisia species and as part of these studies, the structure of the title compound is now reported.

Structural commentary

The mol­ecular structure of the title compound is shown in Fig. 1 ▸. The compound comprises fused cyclo­hexane and cyclo­pentane rings. It has been substanti­ated by a positive LB test (Liebermann Burchard Test), which indicates that it belongs to the sesquiterpene class. The compound is soluble in chloro­form but has poor solubility in methanol.
Figure 1

The mol­ecular structure of the title compound, showing 50% probability displacement ellipsoids for non-H atoms.

The bicyclic skeleton contains one acetyl group at atom C1 of the cyclo­pentane ring, one isopropyl group and one hydroxyl group located at atoms C6 and C7 in the cyclo­hexane ring. An exocyclic olefinic double bond is located between atoms C9 and C15 and attached to the cyclo­hexane ring. The torsion angles C3—C4—C5C6 and C9—C4—C5—C1 of −169.2 (3) and −170.9 (3)°, respectively, describe the geometry at the junction of the two rings. The C7C6C5 and C9—C4—C5 angles are 107.3 (2) and 109.2 (3)°, respectively.

Supra­molecular features

In the crystal, mol­ecules are linked by O—H⋯O hydrogen bonds, forming chains along [010] (Table 1 ▸ and Fig. 2 ▸). These chains are cross-linked by weak C—H⋯O hydrogen bonds.
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
O1—H1O⋯O1i 0.822.112.927 (4)175
C11—H11C⋯O2ii 0.962.533.430 (6)157

Symmetry codes: (i) ; (ii) .

Figure 2

Part of the crystal structure of the title compound, with hydrogen bonds shown as dashed lines.

Database survey

A search of Cambridge Structural Database (CSD, Version 5.36, last update May 2015; Groom & Allen, 2015 ▸) found only one mol­ecule, Pulioplopane A (15-hy­droxy-10 (14)-oplopen-4-one; Triana et al., 2005 ▸) that has a similar structural skeleton to the title sesquitertene although it is is unrelated in a biochemical sense.

Synthesis and crystallization

The title sesquiterpene was isolated as colourless solid from the methanol extract of A. reticulata by chromatography over silica gel with a mixture of ethyl acetate and hexane with a gradient elution followed by preparative thin layer chromatography. Crystals were obtained after recrystallization three times from ethyl acetate:hexane (1:4) at room temperature by the slow evaporation method. Bioassay of this mol­ecule has been conducted against human ovarian cancer cell line A 2780 and revealed that it possessed significant anti­proliferative activity (unpublished results).

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. H atoms were placed in calculated positions with C—H = 0.93–0.98 Å and O—H = 0.82 Å and refined in a riding-motion approximation with U iso(U) = 1.2U eq(C,O). No Friedel pairs were collected therefore the absolute configuration could not be determined from the X-ray data and the assignment is arbitrary.
Table 2

Experimental details

Crystal data
Chemical formulaC15H24O2
M r 236.34
Crystal system, space groupMonoclinic, P21
Temperature (K)299
a, b, c (Å)8.849 (4), 5.336 (1), 14.994 (5)
β (°)99.21 (2)
V3)698.9 (4)
Z 2
Radiation typeCu Kα
μ (mm−1)0.56
Crystal size (mm)0.50 × 0.18 × 0.15
 
Data collection
DiffractometerEnraf–Nonius CAD-4
No. of measured, independent and observed [I > 2σ(I)] reflections1916, 1392, 1260
R int 0.052
(sin θ/λ)max−1)0.597
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.060, 0.164, 1.10
No. of reflections1392
No. of parameters154
No. of restraints1
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.46, −0.22

Computer programs: CAD-4-PC (Enraf–Nonius, 1993 ▸), REDU4 (Stoe & Cie, 1987 ▸), SHELXS97 and SHELXL97 (Sheldrick, 2008 ▸) and PLATON (Spek, 2009 ▸).

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989016003236/lh5803sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016003236/lh5803Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016003236/lh5803Isup3.cml CCDC reference: 1455684 Additional supporting information: crystallographic information; 3D view; checkCIF report
C15H24O2F(000) = 260
Mr = 236.34Dx = 1.123 Mg m3
Monoclinic, P21Cu Kα radiation, λ = 1.54180 Å
Hall symbol: P 2ybCell parameters from 25 reflections
a = 8.849 (4) Åθ = 5.5–27.1°
b = 5.336 (1) ŵ = 0.56 mm1
c = 14.994 (5) ÅT = 299 K
β = 99.21 (2)°Rod, colourless
V = 698.9 (4) Å30.50 × 0.18 × 0.15 mm
Z = 2
Enraf–Nonius CAD-4 diffractometerRint = 0.052
Radiation source: fine-focus sealed tubeθmax = 67.0°, θmin = 3.0°
Graphite monochromatorh = −10→3
ω/2θ scansk = 0→6
1916 measured reflectionsl = −17→17
1392 independent reflections3 standard reflections every 120 min
1260 reflections with I > 2σ(I) intensity decay: 1.0%
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.060Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.164H-atom parameters constrained
S = 1.10w = 1/[σ2(Fo2) + (0.1147P)2 + 0.0812P] where P = (Fo2 + 2Fc2)/3
1392 reflections(Δ/σ)max < 0.001
154 parametersΔρmax = 0.46 e Å3
1 restraintΔρmin = −0.22 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 &gt; σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.5467 (3)0.0974 (5)0.03391 (14)0.0580 (7)
H1O0.52590.23800.01350.070*
O20.9664 (3)0.1293 (5)0.3910 (2)0.0680 (8)
C10.8020 (3)0.4666 (6)0.33401 (19)0.0401 (7)
H10.81840.61680.29920.048*
C20.7177 (4)0.5402 (8)0.4141 (2)0.0539 (9)
H2A0.78210.50690.47150.065*
H2B0.69120.71670.41120.065*
C30.5742 (4)0.3792 (9)0.4035 (2)0.0568 (9)
H3A0.59430.21880.43350.068*
H3B0.49230.46330.42770.068*
C40.5350 (3)0.3473 (7)0.3022 (2)0.0446 (7)
H40.50200.51090.27650.053*
C50.6918 (3)0.2887 (5)0.27514 (17)0.0355 (6)
H50.71910.11740.29520.043*
C60.6880 (3)0.2967 (5)0.17229 (17)0.0370 (7)
H60.65010.46290.15180.044*
C70.5672 (4)0.1059 (6)0.13003 (18)0.0439 (7)
H70.6039−0.06000.15170.053*
C80.4103 (4)0.1446 (9)0.1602 (2)0.0590 (10)
H8A0.36540.29910.13410.071*
H8B0.34290.00810.13710.071*
C90.4206 (4)0.1563 (8)0.2604 (2)0.0508 (8)
C100.9549 (4)0.3515 (7)0.3722 (2)0.0431 (7)
C111.0900 (4)0.5203 (9)0.3893 (3)0.0671 (11)
H11A1.16640.46370.35520.081*
H11B1.13130.51850.45260.081*
H11C1.05940.68780.37130.081*
C120.8473 (4)0.2670 (6)0.1447 (2)0.0447 (8)
H120.91600.37740.18470.054*
C130.8571 (5)0.3509 (9)0.0487 (2)0.0604 (10)
H13A0.82940.52460.04180.072*
H13B0.78820.25240.00670.072*
H13C0.95980.32860.03710.072*
C140.9125 (5)0.0040 (8)0.1601 (3)0.0613 (10)
H14A0.8454−0.11350.12510.074*
H14B0.9217−0.03770.22300.074*
H14C1.0116−0.00270.14190.074*
C150.3418 (5)0.0067 (11)0.3076 (3)0.0708 (12)
H15A0.2759−0.11340.27800.085*
H15B0.35280.02250.37010.085*
U11U22U33U12U13U23
O10.0792 (15)0.0505 (15)0.0419 (11)−0.0110 (14)0.0024 (10)−0.0077 (11)
O20.0730 (17)0.0337 (14)0.0893 (19)0.0019 (14)−0.0110 (13)0.0124 (14)
C10.0543 (16)0.0251 (14)0.0392 (13)−0.0004 (13)0.0022 (12)0.0020 (12)
C20.067 (2)0.045 (2)0.0479 (16)0.0059 (17)0.0046 (14)−0.0101 (16)
C30.0614 (19)0.063 (2)0.0489 (17)0.0040 (18)0.0176 (14)−0.0047 (18)
C40.0501 (16)0.0376 (17)0.0472 (16)0.0042 (15)0.0112 (12)−0.0022 (14)
C50.0451 (14)0.0226 (14)0.0386 (14)−0.0002 (12)0.0059 (11)0.0015 (12)
C60.0513 (16)0.0226 (14)0.0369 (13)0.0002 (13)0.0064 (11)0.0013 (12)
C70.0570 (17)0.0330 (17)0.0410 (14)−0.0066 (15)0.0052 (13)−0.0001 (14)
C80.0527 (18)0.062 (3)0.0603 (19)−0.010 (2)0.0022 (14)−0.004 (2)
C90.0423 (15)0.049 (2)0.0626 (18)−0.0012 (16)0.0135 (13)−0.0002 (17)
C100.0516 (17)0.0324 (16)0.0438 (15)−0.0007 (14)0.0026 (12)−0.0008 (14)
C110.0541 (19)0.047 (2)0.095 (3)−0.0055 (18)−0.0023 (18)−0.002 (2)
C120.0551 (17)0.0307 (16)0.0492 (17)−0.0035 (15)0.0108 (13)−0.0007 (14)
C130.078 (2)0.052 (2)0.0559 (19)−0.004 (2)0.0248 (17)−0.0006 (18)
C140.070 (2)0.042 (2)0.077 (2)0.0144 (19)0.0264 (18)0.0068 (19)
C150.060 (2)0.076 (3)0.080 (2)−0.014 (2)0.0229 (18)−0.004 (2)
O1—C71.424 (3)C7—C81.542 (5)
O1—H1O0.8200C7—H70.9800
O2—C101.219 (5)C8—C91.493 (5)
C1—C101.513 (4)C8—H8A0.9700
C1—C51.535 (4)C8—H8B0.9700
C1—C21.562 (5)C9—C151.335 (6)
C1—H10.9800C10—C111.486 (5)
C2—C31.521 (6)C11—H11A0.9600
C2—H2A0.9700C11—H11B0.9600
C2—H2B0.9700C11—H11C0.9600
C3—C41.513 (4)C12—C141.521 (5)
C3—H3A0.9700C12—C131.523 (5)
C3—H3B0.9700C12—H120.9800
C4—C91.501 (5)C13—H13A0.9600
C4—C51.539 (4)C13—H13B0.9600
C4—H40.9800C13—H13C0.9600
C5—C61.538 (3)C14—H14A0.9600
C5—H50.9800C14—H14B0.9600
C6—C71.537 (4)C14—H14C0.9600
C6—C121.540 (4)C15—H15A0.9300
C6—H60.9800C15—H15B0.9300
C7—O1—H1O109.5C6—C7—H7106.8
C10—C1—C5114.5 (3)C8—C7—H7106.8
C10—C1—C2108.6 (2)C9—C8—C7112.9 (3)
C5—C1—C2105.1 (2)C9—C8—H8A109.0
C10—C1—H1109.5C7—C8—H8A109.0
C5—C1—H1109.5C9—C8—H8B109.0
C2—C1—H1109.5C7—C8—H8B109.0
C3—C2—C1105.8 (3)H8A—C8—H8B107.8
C3—C2—H2A110.6C15—C9—C8123.8 (4)
C1—C2—H2A110.6C15—C9—C4124.0 (4)
C3—C2—H2B110.6C8—C9—C4112.2 (3)
C1—C2—H2B110.6O2—C10—C11121.0 (3)
H2A—C2—H2B108.7O2—C10—C1121.3 (3)
C4—C3—C2102.8 (3)C11—C10—C1117.7 (3)
C4—C3—H3A111.2C10—C11—H11A109.5
C2—C3—H3A111.2C10—C11—H11B109.5
C4—C3—H3B111.2H11A—C11—H11B109.5
C2—C3—H3B111.2C10—C11—H11C109.5
H3A—C3—H3B109.1H11A—C11—H11C109.5
C9—C4—C3121.8 (3)H11B—C11—H11C109.5
C9—C4—C5109.2 (3)C14—C12—C13109.7 (3)
C3—C4—C5102.5 (2)C14—C12—C6113.3 (3)
C9—C4—H4107.5C13—C12—C6114.6 (3)
C3—C4—H4107.5C14—C12—H12106.2
C5—C4—H4107.5C13—C12—H12106.2
C1—C5—C6118.0 (2)C6—C12—H12106.2
C1—C5—C4103.8 (2)C12—C13—H13A109.5
C6—C5—C4112.5 (2)C12—C13—H13B109.5
C1—C5—H5107.3H13A—C13—H13B109.5
C6—C5—H5107.3C12—C13—H13C109.5
C4—C5—H5107.3H13A—C13—H13C109.5
C7—C6—C5107.3 (2)H13B—C13—H13C109.5
C7—C6—C12115.3 (3)C12—C14—H14A109.5
C5—C6—C12113.1 (2)C12—C14—H14B109.5
C7—C6—H6106.9H14A—C14—H14B109.5
C5—C6—H6106.9C12—C14—H14C109.5
C12—C6—H6106.9H14A—C14—H14C109.5
O1—C7—C6113.9 (2)H14B—C14—H14C109.5
O1—C7—C8109.0 (2)C9—C15—H15A120.0
C6—C7—C8112.9 (3)C9—C15—H15B120.0
O1—C7—H7106.8H15A—C15—H15B120.0
C10—C1—C2—C3−116.4 (3)C5—C6—C7—C852.9 (3)
C5—C1—C2—C36.5 (4)C12—C6—C7—C8179.9 (3)
C1—C2—C3—C4−31.5 (4)O1—C7—C8—C9−179.9 (3)
C2—C3—C4—C9166.7 (3)C6—C7—C8—C9−52.2 (4)
C2—C3—C4—C544.5 (4)C7—C8—C9—C15−124.2 (4)
C10—C1—C5—C6−95.1 (3)C7—C8—C9—C453.1 (4)
C2—C1—C5—C6145.9 (3)C3—C4—C9—C152.1 (6)
C10—C1—C5—C4139.6 (3)C5—C4—C9—C15121.1 (4)
C2—C1—C5—C420.5 (3)C3—C4—C9—C8−175.3 (3)
C9—C4—C5—C1−170.9 (3)C5—C4—C9—C8−56.3 (4)
C3—C4—C5—C1−40.5 (3)C5—C1—C10—O2−31.7 (5)
C9—C4—C5—C660.4 (3)C2—C1—C10—O285.3 (4)
C3—C4—C5—C6−169.2 (3)C5—C1—C10—C11150.5 (3)
C1—C5—C6—C7−179.0 (3)C2—C1—C10—C11−92.5 (4)
C4—C5—C6—C7−58.0 (3)C7—C6—C12—C14−53.3 (4)
C1—C5—C6—C1252.8 (3)C5—C6—C12—C1470.7 (4)
C4—C5—C6—C12173.7 (3)C7—C6—C12—C1373.6 (4)
C5—C6—C7—O1178.0 (2)C5—C6—C12—C13−162.4 (3)
C12—C6—C7—O1−55.0 (3)
D—H···AD—HH···AD···AD—H···A
O1—H1O···O1i0.822.112.927 (4)175
C11—H11C···O2ii0.962.533.430 (6)157
  11 in total

1.  Sesquiterpenoids from Pulicaria canariensis and their cytotoxic activities.

Authors:  Jorge Triana; Mariana López; Francisco J Pérez; Javier González-Platas; José Quintana; Francisco Estévez; Francisco León; Jaime Bermejo
Journal:  J Nat Prod       Date:  2005-04       Impact factor: 4.050

2.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

3.  Effects of Artemisia pallens Wall. on blood glucose levels in normal and alloxan-induced diabetic rats.

Authors:  A Subramoniam; P Pushpangadan; S Rajasekharan; D A Evans; P G Latha; R Valsaraj
Journal:  J Ethnopharmacol       Date:  1996-01       Impact factor: 4.360

4.  Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States.

Authors:  D L Klayman; A J Lin; N Acton; J P Scovill; J M Hoch; W K Milhous; A D Theoharides; A S Dobek
Journal:  J Nat Prod       Date:  1984 Jul-Aug       Impact factor: 4.050

5.  The anti-malarial artesunate is also active against cancer.

Authors:  T Efferth; H Dunstan; A Sauerbrey; H Miyachi; C R Chitambar
Journal:  Int J Oncol       Date:  2001-04       Impact factor: 5.650

6.  Antimalaric effect of an alcoholic extract of Artemisia ludoviciana mexicana in a rodent malaria model.

Authors:  F Malagón; J Vázquez; G Delgado; A Ruiz
Journal:  Parassitologia       Date:  1997-03

7.  Antioxidant and hepatoprotective actions of the medicinal herb Artemisia campestris from the Okinawa Islands.

Authors:  Y Aniya; M Shimabukuro; M Shimoji; M Kohatsu; M A Gyamfi; C Miyagi; D Kunii; F Takayama; T Egashira
Journal:  Biol Pharm Bull       Date:  2000-03       Impact factor: 2.233

Review 8.  Malaria: new developments in treatment and prevention.

Authors:  P Newton; N White
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

Review 9.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.